Search

Your search keyword '"Sugimoto M"' showing total 4,469 results

Search Constraints

Start Over You searched for: Author "Sugimoto M" Remove constraint Author: "Sugimoto M"
4,469 results on '"Sugimoto M"'

Search Results

1. Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema in Eyes with Branch Retinal Vein Occlusion with vs Without Glaucoma – Does Glaucoma Affect Visual Outcome in Eyes with BRVO-ME After antiVEGF Injections?

2. Positive Culture Prior to Transperineal Prostate Biopsy Was Not Associated with Post-Biopsy Febrile Urinary Tract Infection Development

4. Efficacy of esomeprazole in treating acid-related diseases in Japanese populations

5. The accomplishment of the Engineering Design Activities of IFMIF/EVEDA: The European Japanese project towards a Li(d,xn) fusion relevant neutron source

6. IFMIF/EVEDA achievements overview

8. Observing the Sun with the Atacama Large Millimeter-submillimeter Array (ALMA): Fast-Scan Single-Dish Mapping

9. Observing the Sun with Atacama Large Millimeter/submillimeter Array (ALMA): High Resolution Interferometric Imaging

14. An Overview of the 2014 ALMA Long Baseline Campaign

16. Comparison of Exhaled Volatile Organic Compounds Among Severe Asthma Phenotypes in Japan: A J-VOCSA Study

17. Long-term outcomes of a multicenter prospective observational study of active surveillance for early-stage prostate cancer: The PRIAS-JAPAN study

19. Laser Thomson scattering system for anisotropic electron temperature measurement in NUMBER

21. Clarification as to why alcoholic beverages have the ability to induce superconductivity in Fe_{1+d}Te_{1-x}S_x

26. Status of the RFQ linac installation and conditioning of the Linear IFMIF Prototype Accelerator

29. Concept of Staged Approach for International Fusion Materials Irradiation Facility

36. Noise Performance Improvements of 2-Layer Transistor Pixel Stacked CMOS Image Sensor with Non-doped Pixel-FinFETs

37. Engineering validation for lithium target facility of the IFMIF under IFMIF/EVEDA project

43. Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial

Catalog

Books, media, physical & digital resources